Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Not Recruiting

Trial ID: NCT01541358

Age - 18 Years-N/A Condition - Bone Cancer, Multiple Myeloma Gender - All Accepting Healthy Volunteers - No

Purpose

This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer

Official Title

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Eligibility


Inclusion Criteria:

   - Patients referred for evaluation of suspected skeletal cancer

   - Patients must understand and voluntarily sign an informed consent form after the
   contents have been fully explained to them

Exclusion Criteria:

   - Patients who cannot complete a PET/CT scan

   - Pregnant women

   - Healthy volunteers

View More
View Less

Intervention(s):

radiation: fluorine F 18 sodium fluoride

procedure: positron emission tomography/computed tomography

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
ccto-office@stanford.edu
650-498-7061

New Trial Alerts

©2024 Stanford Medicine